
VP of #Osteoarthritis Research Programs @ArthritisFdn
Atlanta, GA
Joined July 2020
- Tweets297
- Following311
- Followers245
- Likes132
Jason Kim retweeted
Did someone say double digits? Rumor has it the MGB PIKASO team had their 10th baseline visit last week. 🤫 Way to go team!🥳 Read more about the study here:
Jason Kim retweeted
Happy Monday! What better way to start your week than getting to know OrACORe director Dr. Katz? ☀️Follow the link to check out our most recent blog post on the fascinating life and career of Jeff. oracore.bwh.harvard.edu/leap…
Jason Kim retweeted
A little birdie told me the CoMeT study surpassed 90 randomizations last week... You guys are unstoppable! 💫🌟🌠
For more information on the CoMeT study, click here: oracore.bwh.harvard.edu/come…
Jason Kim retweeted
With our colleagues at University of Kentucky now officially recruiting, we now have 6/9 PIKASO sites actively up and running! Three more to go and this study will be enrolling with full force 💪💪
oracore.bwh.harvard.edu/pika…
Honored. Thanks @ArthritisFdn
Osteoarthritis is a complicated disease to study, but @JasonKimAF, PhD, VP of Osteoarthritis Research, is focused on bringing together patients, scientists and health care providers to improve infrastructure of clinical trials. arthr.org/3UxiXLH
#ArthritisScience
The amazing Lily Waddell of @OrACORe_BWH profiled for her work in #osteoarthritis and the @ArthritisFdn sponsored PIKASO Trial studying metformin in knees at risk of PTOA.
Read her Q&A here! bit.ly/3TFtF4d
We worked with @HSSProfEd to think and talk about hip #osteoarthritis--and now are issuing an RFP
with the goal of identifying patients with risk of accelerated hip OA for future clinical studies.
See RFP and Apply Here:
proposalcentral.com/Proposal…
Hip, hip, hooray - our November special issue on the 2023 Hip Osteoarthritis Clinical Studies Conference, a collaboration of @ArthritisFdn and @HSpecialSurgery, is online! #OrthoTwitter journals.sagepub.com/toc/hss…
When was the last time you thought about hip #osteoarthritis?
Always can count on @oaactionallianc to spread the word on what we are working on at @ArthritisFdn in collab with @HSSProfEd
Research Roundup for 11/13: The latest in #osteoarthritis research - mailchi.mp/unc/research-roun… @JasonKimAF
Jason Kim retweeted
Hip, hip, hooray - our November special issue on the 2023 Hip Osteoarthritis Clinical Studies Conference, a collaboration of @ArthritisFdn and @HSpecialSurgery, is online! #OrthoTwitter journals.sagepub.com/toc/hss…
Important finding from @AOSSM_SportsMed Meeting: PICKLEBALL!
@ArthritisFdn
Jason Kim retweeted
Fun time at the Boston @ArthritisFdn walk, adults and kids alike
OA got Patty Kane. apnews.com/article/patrick-k…
Jason Kim retweeted
Deadline to submit letters of intent for our 2023 Rheumatoid Arthritis Research Program is this Wed., May 17. Grant funding is available for projects designed to improve understanding of how patients with RA respond to varying therapeutics. bit.ly/3XSN8ga
Jason Kim retweeted
The first OA Innovation Shark Tank program tomorrow, hosted by @AngryArthritis and the @ArthritisFdn, will bring together the leading minds in OA research to present their treatments, opinions, research, and human clinical trial data.
More info here: angryarthritis.org/oa-innova…
Jason Kim retweeted
Thank you to the @ArthritisFdn, our speakers, and everyone who attended to support our mission today. Stay connected with us on our website as we work to achieve the promise of new treatments to cure osteoarthritis: angryarthritis.org/ (3/3)
We’re honored to have an amazing array of speakers join us today to present their treatments, opinions, research, and clinical trial data as we make the case for additional investment from the government in finding an #osteoarthritis cure (2/3)
Jason Kim retweeted
Today’s the day 📅 In Capitol Hill, we’re hosting the first annual new science OA “shark-tank” meeting alongside the @ArthritisFdn (1/3)
Compelling words by @GerryConnolly at Hill event for more #osteoarthritis funding @ArthritisFdn @angryarthritis



































